Literature DB >> 165862

Neutral red with photoinactivation in the treatment of herpes genitalis.

A P Roome, A E Tinkler, A L Hilton, D G Montefiore, D Waller.   

Abstract

A clinical trial was undertaken to compare the efficacy of neutral red photodynamic inactivation treatment of genital herpes infections with that of a non-photoactive dye, phenol red, as a control. In a series of nineteen patients with virologically proven herpes genitalis who were adequately followed, eleven were treated with neutral red, and eight with phenol red; no difference in response to therapy was found between the two groups, and it is concluded that under the conditions of this trial neutral red with photoinactivation was not effective in the treatment of acute genital herpes infections. Approximately 75 per cent. of those with vulval lesions also had concurrent cervical infection, so that an effective topical treatment would need to be applicable to both anatomical sites.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165862      PMCID: PMC1045129          DOI: 10.1136/sti.51.2.130

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  13 in total

1.  IRREVERSIBLE PHOTOSENSITIZATION OF VIRUSES.

Authors:  C WALLIS; J L MELNICK
Journal:  Virology       Date:  1964-08       Impact factor: 3.616

2.  Aetiology of Pancreatic Apoplexy.

Authors:  J T Chesterman
Journal:  Br Med J       Date:  1945-10-06

3.  Clinical features of herpes genitalis.

Authors:  R H Kaufman; H L Gardner; W E Rawls; R E Dixon; R L Young
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

4.  Photodynamic inactivation in the treatment of experimental herpes simplex keratitis.

Authors:  J V Thomas; W A Dunlap; A M Rich
Journal:  Br J Ophthalmol       Date:  1973-05       Impact factor: 4.638

5.  Characterization of genital strains of Herpesvirus hominis.

Authors:  I W Smith; J F Peutherer; D H Robertson
Journal:  Br J Vener Dis       Date:  1973-08

6.  Herpes genitalis: management--present and predicted.

Authors:  C Wallis; J L Melnick; R H Kaufman
Journal:  Clin Obstet Gynecol       Date:  1972-12       Impact factor: 2.190

7.  Genital herpes in two social groups.

Authors:  W E Rawls; H L Gardner; R W Flanders; S P Lowry; R H Kaufman; J L Melnick
Journal:  Am J Obstet Gynecol       Date:  1971-07-01       Impact factor: 8.661

8.  Photodynamic inactivation with proflavine: quantitative comparison with iodo-deoxyuridine.

Authors:  E D Varnell; H E Kaufman
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

9.  Hepres genitalis; clinical and cytopathologic experience with 256 patients.

Authors:  A B Ng; J W Reagan; S S Yen
Journal:  Obstet Gynecol       Date:  1970-10       Impact factor: 7.661

10.  Antibodies to Herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections.

Authors:  A J Nahmias; W E Josey; Z M Naib; C F Luce; A Duffey
Journal:  Am J Epidemiol       Date:  1970-06       Impact factor: 4.897

View more
  8 in total

1.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

Review 2.  Photodynamic therapy for infections: clinical applications.

Authors:  Gitika B Kharkwal; Sulbha K Sharma; Ying-Ying Huang; Tianhong Dai; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

3.  Clinical and virologic course of herpes simplex genitalis.

Authors:  Z A Brown; E R Kern; S L Spruance; J C Overall
Journal:  West J Med       Date:  1979-05

Review 4.  Photodynamic therapy for localized infections--state of the art.

Authors:  Tianhong Dai; Ying-Ying Huang; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2009 Sep-Dec       Impact factor: 3.631

5.  Current approaches to the diagnosis of herpes genitalis.

Authors:  E M Belsey; M W Adler
Journal:  Br J Vener Dis       Date:  1978-04

6.  Early events in herpes simplex virus type 1 infection: photosensitivity of fluorescein isothiocyanate-treated virions.

Authors:  N DeLuca; D Bzik; S Person; W Snipes
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

7.  Eradication of bacteria in suspension and biofilms using methylene blue-loaded dynamic nanoplatforms.

Authors:  Jianfeng Wu; Hao Xu; Wei Tang; Raoul Kopelman; Martin A Philbert; Chuanwu Xi
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

8.  In vitro and in vivo photosensitized inactivation of dermatophyte fungi by heterotricyclic dyes.

Authors:  C Propst; L Lubin
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.